维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="DAHABREH I J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Patent foramen ovale closure and medical treatments for secondary stroke preven- tion: a systematic review of observational and randomized evidence 显示文摘	Kitsios GD Dahabreh I J Abu-Dabrh AM	2012	Stroke2012，43，：	1
2	EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment:a systematic review and meta analysis in non-small-cell lung cancer显示文摘	Dahabreh I J Linardou H Kosmidis P	2011	Ann Oncol2011，22，3：	1
3	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh I J Bafaloukos D et at	2009	Nat Rev Clin Oncol2009，6，6：	1
4	As- sessment of somatic k-ras mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in ad- vanced non-small-cell lung cancer and metastatic colo- rectal cancer显示文摘	Linardou H Dahabreh I J Kanaloupiti D	2005	Lancet Oncol2005，9，10：	1
5	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta- analysis of studies in advanced non-small-cell lung cancer and metastatic eolorectal cancer 显示文摘	LINARDOU H DAHABREH I J KANALOUPITI D	2008	Lancet Oncol2008，9，10：	1
6	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted a- gents:a systematic review and recta-analysis of studies in ad- vanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh I J Kanaloupiti D Siannis F Bafaloukos D Kosmidis P	2008	Lancet Oncol2008，9，：	1
7	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EG- FR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer 显示文摘	Linardou H Dahabreh I J Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
8	Device closure of pa- tent foramen ovale after stroke : pooled analysis of completed ran- domized trials 显示文摘	Kent DM Dahabreh I J Ruthazer R	2016	J Am Coil Cardiol2016，67，8：	1
9	Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer显示文摘	Dahabreh I J Linardou H Siannis F	2010	Clin Cancer Res2010，16，1：	1
10	Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies显示文摘	Dahabreh I J Trikahnos T A Paulus J K	2012	Lung Cancer2012，76，2：	1
11	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell hmg cancer and metastatic col orectal cancer显示文摘	Linardou H Dahabreh I J Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
12	Patent foramen ovale closure and medical treatments for secondary stroke prevention:a systematic review of observational and randomized evidence 显示文摘	Kitsios GD Dahabreh I J Abu Dabrh AM	2012	Stroke2012，43，：	1
13	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer 显示文摘	Linardou H Dahabreh I J Kanaloupiti D	2008	Lancet Oncol2008，9，：	1
14	Assessment of somatic k-RAS mutations asa mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta-analysis of studies in advanced non-small-celllung cancer and metastatic colorectal cancer显示文摘	LINARDOU H DAHABREH I J KANALOUPITI D	2008	Lancet Oncol2008，9，10：	1
15	Do observational studies using propensity score methods agree with randomized tri- Ms A systematic comparison of studies on acute coronary syn- dromes 显示文摘	Dahabreh I J Sheldrick R C Paulus J K	2012	Eur Heart J2012，33，15：	1
16	Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systema- tic review and meta-analysis of randomized controlled trials 显示文摘	Dahabreh I J Linardou H Siannis F	2008	Oncologist2008，13，6：	1
17	Lack of replication for theassociation between HER2 I655V polymorphism and breastcancer risk: a systematic review and meta-analysis 显示文摘	DAHABREH I J MURRAY S	2011	Cancer Epidemiol2011，35，6：	1
18	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC显示文摘	Linardou H Dahabreh I J Bafaloukos D	2009	Nat Rev Clin Oncol2009，6，6：	1
19	Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer 显示文摘	Dahabreh I J Linardou H Siannis F	2010	Clin Cancer Res2010，16，1：	1
20	Assessment of K-RAS mutations as a mechanism associated with resistance to EGFR targeted agents: a systematic review and meta-analysis of studies in advanced non-small cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh I J Kanaloupiti D	2008	The Lancet Oncology2008，9，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示